Data · dataset · 2026
<p>Pools of <i>Francisella</i> MHC-II peptides elicit time-dependent, specific and CD4<sup>+</sup> T cell-mediated IFN-γ response in immune splenocytes.</p>
Listed in ZivaHub
<p>C57Bl/6 mice were subcutaneously injected with 3 × 10<sup>4</sup> CFU of <i>F. tularensis</i> LVS and immune lymphocytes, pooled from groups of 3-4 mice, were stimulated with bacterial MHC-II peptides assembled in pools for immunogenicity assessment.
Description
The numbers of IFN-γ producing cells (SFCs) were determined at 3, 4 and 5 weeks p.i. following stimulation of (A) 5 × 10<sup>5</sup> whole splenocytes or (B) cocultures of 3 × 10<sup>5</sup> spleen CD4<sup>+</sup> T cells and 3 × 10<sup>4</sup> BMDCs with peptide pools (PP).
Data of individual assayed wells per condition and mean values are shown. PPs with significant response against control without peptides (unstim) were detected with one-way ANOVA followed by Sidak’s post hoc test. The specificity with which the peptide-induced IFN-γ production depended on immune status of lymphocytes was verified by stimulation of (C) 5 × 10<sup>5</sup> whole splenocytes (3 weeks p.i.) or (D) cocultures of 3 × 10<sup>5</sup> spleen CD4<sup>+</sup> T cells (4 weeks p.i.) and 3 × 10<sup>4</sup> BMDCs with PP-3.
Read the rest (4 more)
Lymphocytes were isolated from LVS immunized (immune) or age-matched control (control) mice. Data of individual assayed wells per condition and mean values are shown. Responses were assessed for significant difference using a two-tailed t-test.
(E) IFN-γ and (F) TNF-α concentrations were determined by ELISA in cell culture supernatants of 8 × 10<sup>5</sup> LVS-immune splenocytes (3 weeks p.i.) after 48 h of PPs stimulation. Data of 3 biological replicates and mean values are shown. PPs with significant response against control without peptides were detected with one-way ANOVA followed by Dunnett’s post hoc test.
PPs representing a subset of 15 peptides (Table B in <a href="plospathogens.org/article/info:doi/10.1371/journal.ppat.1014597#ppat.1014597.s002" target="_blank">S1 Appendix</a>) were used for all assays with 5 µM final concentration of each peptide. Ova II peptide (5 µM) was used as a negative control in some experiments. Asterisks indicate p-values (**p < 0.01, ***p < 0.001, ****p < 0.0001, ns for p ≥ 0.05).
Data are results of one experiment (A, B, C) or representative results of two biological replicates (D).</p>
Links
Where it is published
- DOI doi.org/10.1371/journal.ppat.1014597.g003 ↗
DOI / persistent id · from zivahub uct ac za
Catalogue records · 1
- OAI-PMH record api.figshare.com/v2/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Af… ↗
metadata API · from zivahub uct ac za
Topics
- From keywords
- Biochemistry and cell biology · Cancer · Earth & Environmental Science · Immunology · Infectious diseases · Life Sciences · Medicine & Health · Microbiology
- Inferred from text
- Tabular 65%
Provenance · 1 source records, 14 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| ZivaHub | oai:figshare.com:article/34026925 | 11 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| access_level | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[disease].local:disease:cancer | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Cancer'] |
| concepts[field].anzsrc:field:320211 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Infectious Diseases'] |
| concepts[field].anzsrc:group:3101 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Cell Biology'] |
| concepts[field].anzsrc:group:3107 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Microbiology'] |
| concepts[field].anzsrc:group:3204 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Immunology'] |
| concepts[field].local:field:earth-environmental | mapping · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[field].local:field:life-sciences | mapping · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[field].local:field:medicine-health | mapping · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[modality].local:modality:tabular | enrichment · zivahub uct ac za | keyword-concept-rules@1.0.0 | title+description (65%) |
| description | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/description |
| license | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/rights |
| publication_date | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| title | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/title |